Clinical trial
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
NCT00766168 is registered in ClinicalTrials.gov with CooperVision International Limited (CVIL) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
- Lead sponsor
- CooperVision International Limited (CVIL)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- August 31, 2008
- Enrollment
- 76 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.